TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,249
|
1,093
|
322 |
Financial expenses |
0
|
1
|
35 |
Earnings before taxes |
-14,094
|
-13,608
|
-12,255 |
EBITDA |
-7,354
|
-7,347
|
-6,311 |
Total assets |
25,019
|
34,617
|
37,485 |
Current assets |
4,940
|
10,824
|
8,688 |
Current liabilities |
1,444
|
1,913
|
2,365 |
Equity capital |
23,575
|
32,704
|
35,120 |
- share capital |
2,926
|
1,693
|
1,025 |
Employees (average) |
5
|
6
|
5 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
94.2%
|
94.5%
|
93.7% |
Turnover per employee |
250
|
182
|
64 |
Profit as a percentage of turnover |
-1128.4%
|
-1245.0%
|
-3805.9% |
Return on assets (ROA) |
-56.3%
|
-39.3%
|
-32.6% |
Current ratio |
342.1%
|
565.8%
|
367.4% |
Return on equity (ROE) |
-59.8%
|
-41.6%
|
-34.9% |
Change turnover |
188
|
794
|
322 |
Change turnover % |
18%
|
265% | |
Chg. No. of employees |
-1
|
1
|
-2 |
Chg. No. of employees % |
-17%
|
20%
|
-29% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.